Robert E. Claypoole serves as Executive at Bioventus Inc., where they oversee executive responsibilities. Since joining the company, Robert E. Claypoole has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 9, 2026 involved exercising options for 93,750 shares valued at $0.
Robert E. Claypoole currently holds 187,500 shares of Bioventus Inc. (BVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert E. Claypoole has been a net neutral trader of BVS stock. They have purchased $0 and sold $0 worth of shares.
Robert E. Claypoole's most recent insider trade was on Jan 9, 2026, when they sold 93,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.03 |
| Discretionary |
| Jan 9, 2026 | BVS | $0 | Option Exercise | 93,750 | $N/A | Discretionary |